Who
Parvinder Thiara
Director
Company insider
Files Form 4 as: Director and 10% owner, Zura Bio; Director, Tourmaline Bio.
In numbers
- Trades disclosed
- 20
- Buys
- 3
- Sells
- 3
- Bought
- $95K
- Sold
- $21.0M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 19 Oct 2023
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —38,823 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —38,823 at $0.00 | filing |
| 28 Oct 2025filed 28 Oct 2025 | Tourmaline Biooption or derivative | SEC FORM 4 Code D | —10,000 | filing |
| 28 Oct 2025filed 28 Oct 2025 | Tourmaline Biooption or derivative | SEC FORM 4 Code D | —10,000 | filing |
| 28 Oct 2025filed 28 Oct 2025 | Tourmaline Biooption or derivative | SEC FORM 4 Code D | —16,800 | filing |
| 28 Oct 2025filed 28 Oct 2025 | Tourmaline Bio | SEC FORM 4 Code U | —83,782 | filing |
| 4 Jun 2025filed 6 Jun 2025 | Tourmaline Biooption or derivative | SEC FORM 4 Code A | —16,800 at $0.00 | filing |
| 9 Dec 2024filed 11 Dec 2024 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —117,000 at $0.00 | filing |
| 25 Nov 2024filed 27 Nov 2024 | ZURA Zura BioBiotechnology | SEC FORM 4 Sold | $2.7M1,001,633 at $2.73 | filing |
| 11 Sep 2024filed 13 Sep 2024 | ZURA Zura BioBiotechnology | SEC FORM 4 Sold | $10.3M3,800,000 at $2.70 | filing |
| 5 Jun 2024filed 7 Jun 2024 | Tourmaline Biooption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —48,149 at $0.00 | filing |
| 12 Dec 2023filed 14 Dec 2023 | ZURA Zura BioBiotechnology | SEC FORM 4 Sold | $8.0M2,000,000 at $4.00 | filing |
| 17 Nov 2023filed 20 Nov 2023 | Tourmaline Bio | SEC FORM 4 Bought | $17K1,000 at $17.31 | filing |
| 25 Oct 2023filed 26 Oct 2023 | Tourmaline Bio | SEC FORM 4 Bought | $24K2,000 at $12.12 | filing |
| 24 Oct 2023filed 26 Oct 2023 | Tourmaline Bio | SEC FORM 4 Bought | $53K5,000 at $10.66 | filing |
| 23 Oct 2023filed 23 Oct 2023 | Tourmaline Biooption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 Oct 2023filed 23 Oct 2023 | Tourmaline Bio | SEC FORM 4 Code A | —75,782 | filing |
News
Zura Bio Limited (NASDAQ:ZURA) Stock Has Average Price Target of $17.00ZURA · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Parvinder Thiara; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.